Marllor Biomedical
Marllor Biomedical, founded in 2009 by Dr. Pasquale Motolese and Vania Bedetti, is an Italian company renowned for its innovative contributions to non-surgical aesthetic medicine. Headquartered in San Giovanni in Marignano, Italy, Marllor Biomedical specializes in the development and production of medical devices and procedures that enhance patient confidence and aesthetics. The company is best known for its groundbreaking products, such as Aqualyx, a fat-dissolving solution, and Alidya, the first injectable specifically designed to treat cellulite. These products are widely recognized for their effectiveness and have established a strong presence in over 60 countries globally. Marllor Biomedical emphasizes high standards of quality, adhering to ISO, CE, and GMP certifications. Their commitment to scientific research and innovation ensures that they remain at the forefront of the aesthetic medicine industry. The company's extensive product portfolio also includes Lipoinject and Mesoinject, further showcasing their dedication to providing comprehensive aesthetic solutions.
Marllor Biomedical Introduction
The Italian company Marllor Biomedical designs, develops and markets medical device technology and provides a technical contribution to the scientific leading non-surgical procedures in medicine and cosmetic dermatology, since 2007. Research and development are the primary objective of Marllor Biomedichal. The major investments are focused on clinical studies, quality and device registration.
Marllor Biomedichal is launching new products by integrating regulatory issues into all of its R&D activities from start to finish. The company has the total exclusive sale of Aqualyx®, the only device in the world indicated for the treatment of localized adiposity.